Article
Treatment and survival study in the C57BL/6J-APC(Min)/+(Min) mouse with R-flurbiprofen.
Life sciences - 14 Jan 2000
Wechter W J, Murray E D, Kantoci D, Quiggle D D, Leipold D D, Gibson K M, McCracken J D
Abstract excerpt
Our previous studies with the mouse model of familial adenomatous polyposis (FAP), C57BL/6J-APC(Min)/+ or Min mouse, demonstrated the optimal dose for adenoma reduction with R-flurbiprofen was 10 mg/kg/day as an undivided dose. Divided doses exhibited no increased efficaciousness. This study examines 10 mg/kg R-flurbiprofen daily (qd) on survival as well as a second daily (q.o.d.) schedule and compares it with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
